tiprankstipranks
Trending News
More News >

Luke Evnin Insider Profile

4 Followers
Luke Evnin, Ten Percent Owner at Epirus Biopharma, holds 11.13M shares in Epirus Biopharma (Ticker: EPRSQ), holds 6.36M shares in Poniard Pharmaceuticals (Ticker: PARD), holds ― shares in Syndax Pharmaceuticals (Ticker: SNDX). Most recently, Luke Evnin Sold ― shares of Epirus Biopharma on Oct 28, 2011 for an estimated value of 760.97K.
tipranks
Luke Evnin

Luke Evnin
Epirus Biopharma (EPRSQ)
Ten Percent Owner

Ranked #1,105 out of 78,624 Corporate Insiders

Profitable Transactions

83%
24 out of 29 Profitable Transactions

Average Return

+25.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$405M
23.17%
16.59%
16.50%
15.48%
28.27% Others
A breakdown of Luke Evnin's holdings

Insider Roles

Radius Health
(RDUS)
Ten Percent Owner
Harpoon Therapeutics
(HARP)
Director, Ten Percent Owner
Altimmune
(ALT)
Ten Percent Owner
Oncorus
(ONCR)
Director, Ten Percent Owner
+8 other positions
Roles that Luke Evnin holds in companies

Most Profitable Insider Trade

Stock:
Pacira Pharmaceuticals
(PCRX)
Rating:Informative Buy
Date:Nov 22, 2011 - Nov 22, 2012
Return:+114.10%
The most profitable trade made by Luke Evnin

Luke Evnin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Epirus Biopharma
Oct 28, 2011
Ten Percent Owner
Informative Sell
760.97K
$155.88K
Poniard Pharmaceuticals
Nov 09, 2009
Ten Percent Owner
Uninformative Sell
4.05M
$394.52K
Syndax Pharmaceuticals
Director, Ten Percent Owner
Harpoon Therapeutics
Feb 14, 2019
Director, Ten Percent Owner
Informative Buy
3.50M
$67.14M
Oncorus
Oct 08, 2020
Director, Ten Percent Owner
Uninformative Buy
$62.65M
Pacira Pharmaceuticals
Jun 13, 2013
Director
Uninformative Sell
683.80K
$52.59M
Epizyme
Feb 11, 2014
Ten Percent Owner
Informative Sell
13.65M
$29.28M
Altimmune
Nov 05, 2010
Ten Percent Owner
Informative Buy
7.67M
$66.78M
Humanigen
Ten Percent Owner
$25.12M
Histogen
Aug 01, 2013
Ten Percent Owner
Uninformative Buy
183.88K
$1.93M
ReShape Lifesciences
Jan 09, 2014
Director
Informative Sell
1.39M
$4.95M
SOMX
Somaxon Pharmaceuticals
Radius Health
Sep 29, 2016
Ten Percent Owner
Uninformative Sell
$93.77M
List of latest transactions for each holding click on a transaction to see Luke Evnin's performance on stock

Luke Evnin insider profile FAQ

What is the percentage of profitable transactions made by Luke Evnin?
The percentage of profitable transactions made by Luke Evnin is 83%.
    What is the average return per transaction made by Luke Evnin?
    The average return per transaction made by Luke Evnin is 25.20%.
      What stocks does Luke Evnin hold?
      Luke Evnin holds: EPRSQ, PARD, SNDX, HARP, ONCR, PCRX, EPZM, ALT, HGEN, HSTO, RSLS, SOMX, RDUS stocks.
        What was Luke Evnin’s latest transaction?
        Luke Evnin latest transaction was an Informative Sell of $760.97K.
          What was Luke Evnin's most profitable transaction?
          Luke Evnin’s most profitable transaction was an Informative Buy of PCRX stock on November 22, 2011. The return on the trade was 114.10%.
            What is Luke Evnin's role in Epirus Biopharma?
            Luke Evnin's role in Epirus Biopharma is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.